Concepedia

Dennis Garwacki

DG

2

Publications

367

Citations

2

H-Index

2014

Active since

Affiliations

University of Ottawa(Current)

Dennis Garwacki is an author at University of Ottawa specializing in immunology, multiple sclerosis, and neuroimmunology.

Top concepts

Publications per year

2014–2018

2

Publications

2

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

, , +8

Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab

Reuben Valenzuela, John H. Pula, Dennis Garwacki et al. · Journal of the Neurological Sciences · 2014 · 40 citations

, , +7

Rows per page

1–2 of 2